WAG
HZNP

Wallace Advisory Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wallace Advisory Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,813
Closed -$320K – 192
2022
Q4 		$320K Buy
+2,813
New +$320K 0.25% 110